Elena Caron
Neuromuscular Medicine · Memphis, TNNPI 1356544340
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.6% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $457, more than ten times the $37 reported in 2019.
Across 54 payments — averaging $28.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- NS Pharma, Inc.$343
- Sarepta Therapeutics, Inc.$277
- UCB, Inc.$221
- SK Life Science, Inc.$91
- Biogen$81
- ITF Therapeutics LLC$68
- plus $462 from 17 others
Across 41 payments — averaging $3300.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$68K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$40K
- CSL Behring$27K
What the payments were for
- Food & beverage$1,44594%
- Education$986%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| NS Pharma, Inc. | 8 | $343 |
| Sarepta Therapeutics, Inc. | 4 | $277 |
| UCB, Inc. | 12 | $221 |
| SK Life Science, Inc. | 4 | $91 |
| Biogen | 1 | $81 |
| ITF Therapeutics LLC | 2 | $68 |
| Neurelis, Inc. | 3 | $62 |
| Catalyst Pharmaceuticals, Inc. | 2 | $46 |
| Greenwich Biosciences, Inc. | 2 | $37 |
| Upsher-smith Laboratories LLC | 1 | $36 |
| Eisai Inc. | 2 | $33 |
| PTC Therapeutics, Inc. | 1 | $32 |
| Aquestive Therapeutics, Inc. | 2 | $29 |
| Novartis | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Otter Pharmaceuticals, LLC | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Biocodex, Inc. | 1 | $18 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $17 |
| Livanova USA, Inc. | 1 | $15 |
| Travere Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VILTEPSO$110
How this compares
Too few neuromuscular medicine providers in Tennesseeto place this figure against a meaningful peer group, so we don't.
Other neuromuscular medicine in Memphis
- Daniel Guillen MendozaMemphis$65K
- Joshua AlpersChattanooga$623K
- Amanda PeltierNashville$235K
- Peter DonofrioNashville$47K
- Lindsay MalatestaNashville$24K
- Stephen LayfieldNashville$2K
- Madhura LayfieldNashville$2K
- John SturgisNashville$1K
- Christopher LeeNashville$379
- Joel TorresKnoxville$294
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.